Press Releases

  • Cheryl Lubbert, CEO of Reverba Global, Named 2026 HBA Luminary Award Honoree
    Cheryl Lubbert, CEO of Reverba Global, Named 2026 HBA Luminary Award Honoree

    Cheryl Lubbert, CEO of Reverba Global, has been named a 2026 Luminary Award honoree by the Healthcare Businesswomen’s Association. The recognition reflects Cheryl’s leadership in advancing scientific engagement and patient-centered…

  • Reverba Global Introduces ClinOps G.P.S.™ to Set a New Course for Clinical Trial Execution and Chart a Clearer Path from Protocol to Completion
    Reverba Global Introduces ClinOps G.P.S.™ to Set a New Course for Clinical Trial Execution and Chart a Clearer Path from Protocol to Completion

    Comprehensive clinical operations navigation system aligns sponsors, CROs, investigators, sites and patients to improve trial planning, performance and outcomes Implementation with a top 15 global pharmaceutical company demonstratedmeasurable and significant…

  • Reverba Unveils Updated Brand Identity as Reverba Global™, Reflecting the Company’s Expansion and Global Capabilities as a Leader in Healthcare Engagement
    Reverba Unveils Updated Brand Identity as Reverba Global™, Reflecting the Company’s Expansion and Global Capabilities as a Leader in Healthcare Engagement

    Seattle, WA – April 07, 2025 – Reverba, a leader in healthcare engagement, today announced its rebranding as Reverba Global in response to accelerated company growth and international scope. At…